Guardant Health stock gain after FDA clearance (May 20, 2026)
DATA LAYERS COMBINED
2
Genomic + epigenomic signals in a single blood draw — a first
GLOBAL LIQUID BIOPSY MARKET
$5.8B
Estimated 2025 market size; projected to exceed $20B by 2032
CANCER TYPES ADDRESSED
50+
Solid tumor types detectable via circulating tumor DNA (ctDNA)
GLOBAL LIQUID BIOPSY MARKET SIZE (USD BILLIONS) — 2016–2032
ACTUAL MARKET SIZE
PROJECTED
Market grew from $0.7B in 2016 to an estimated $5.8B in 2025. The FDA clearance of the first combined genomic-epigenomic liquid biopsy panel in May 2026 is projected to accelerate adoption, with the market expected to exceed $21B by 2032.